Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$848M |
| 2 |
Tesla
TSLA
|
+$759M |
| 3 |
Home Depot
HD
|
+$653M |
| 4 |
Meta Platforms (Facebook)
META
|
+$567M |
| 5 |
Wells Fargo
WFC
|
+$421M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$786M |
| 2 |
Berkshire Hathaway Class A
BRK.A
|
+$409M |
| 3 |
Micron Technology
MU
|
+$379M |
| 4 |
AT&T
T
|
+$372M |
| 5 |
Medtronic
MDT
|
+$370M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.03% |
| 2 | Technology | 14.98% |
| 3 | Consumer Discretionary | 11.43% |
| 4 | Consumer Staples | 10.71% |
| 5 | Communication Services | 8.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
Alico
ALCO
$297M
| $1.34M | ﹤0.01% |
35,805
-7,600
| -18% | -$264K |
|
2527
MediaAlpha
MAX
$807M
| $1.34M | ﹤0.01% |
81,200
+64,300
| +380% | +$900K |
|
2528
iShares MSCI EAFE Min Vol Factor ETF
EFAV
$5.48B
| $1.34M | ﹤0.01% |
+18,600
| New | +$1.35M |
|
2529
Caribou Biosciences
CRBU
$157M
| $1.33M | ﹤0.01% |
145,100
+49,151
| +51% | +$518K |
|
2530
iShares MSCI France ETF
EWQ
$332M
| $1.33M | ﹤0.01% |
37,700
+13,200
| +54% | +$484K |
|
|
GFED
2531
DELISTED
Guaranty Federal Bancshares In
GFED
| $1.33M | ﹤0.01% |
42,300
-400
| -0.9% | -$13K |
|
|
CTEV
2532
Claritev Corp
CTEV
$646M
| $1.33M | ﹤0.01% |
7,095
-17,915
| -72% | -$2.95M |
|
|
APTO
2533
DELISTED
Aptose Biosciences, Inc.
APTO
| $1.33M | ﹤0.01% |
2,170
+75
| +4% | +$41.5K |
|
2534
Great Elm Group
GEG
$67.7M
| $1.32M | ﹤0.01% |
731,376
-27,500
| -4% | -$53.6K |
|
2535
Sotera Health
SHC
$5.39B
| $1.32M | ﹤0.01% |
61,100
+48,400
| +381% | +$1.03M |
|
2536
Clear Channel Outdoor Holdings
CCO
$1.19B
| $1.32M | ﹤0.01% |
382,074
-147,518
| -28% | -$501K |
|
2537
Five Point Holdings
FPH
$371M
| $1.32M | ﹤0.01% |
216,203
-112,854
| -34% | -$691K |
|
2538
TAT Technologies
TATT
$542M
| $1.32M | ﹤0.01% |
206,500
-6,100
| -3% | -$38.2K |
|
|
ENV
2539
DELISTED
ENVESTNET, INC.
ENV
| $1.32M | ﹤0.01% |
+17,700
| New | +$1.3M |
|
2540
Coffee Holding Co
JVA
$20.2M
| $1.32M | ﹤0.01% |
381,544
-13,502
| -3% | -$55.5K |
|
2541
ICF International
ICFI
$1.59B
| $1.31M | ﹤0.01% |
+13,900
| New | +$1.3M |
|
2542
Vince Holding Corp
VNCE
$80.9M
| $1.31M | ﹤0.01% |
161,048
-10,509
| -6% | -$86.8K |
|
2543
Kirby Corp
KEX
$7.32B
| $1.31M | ﹤0.01% |
18,100
-98,300
| -84% | -$6.55M |
|
|
SOVO
2544
DELISTED
Sovos Brands, Inc. Common Stock
SOVO
| $1.3M | ﹤0.01% |
92,000
-116,600
| -56% | -$1.56M |
|
|
USAP
2545
DELISTED
Universal Stainless & Alloy
USAP
| $1.3M | ﹤0.01% |
149,775
+59,943
| +67% | +$548K |
|
2546
Outlook Therapeutics
OTLK
$141M
| $1.3M | ﹤0.01% |
36,460
-21,755
| -37% | -$679K |
|
2547
Urban One Class D
UONEK
$23.4M
| $1.3M | ﹤0.01% |
25,170
-1,290
| -5% | -$55.6K |
|
2548
Greif Class B
GEF.B
$4.2B
| $1.29M | ﹤0.01% |
20,310
-400
| -2% | -$23.6K |
|
|
ADN
2549
DELISTED
Advent Technologies
ADN
| $1.29M | ﹤0.01% |
18,593
+17,210
| +1,244% | +$1.95M |
|
2550
ENI
E
$79.8B
| $1.29M | ﹤0.01% |
+44,250
| New | +$1.32M |
|
Similar funds
Jim Simons's Q1 2022 Portfolio in Review
As of Q1 2022, Jim Simons held 4,686 positions worth $85.2B, up 6% from $80.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons deployed $8.98B of net new capital in Q1 2022, opening 822 new positions and adding to 1,556 existing holdings. Its largest new stake was Advanced Micro Devices: 7,107,290 shares worth $777M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 20% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Berkshire Hathaway Class A, an estimated $409M trimmed.
- Jim Simons's largest Q1 2022 buy was Advanced Micro Devices: 7,107,290 shares worth $777M.
- Jim Simons added most to Tesla in Q1 2022, an estimated $759M increase.
- Jim Simons's biggest Q1 2022 reduction was Berkshire Hathaway Class A, cutting an estimated $409M.
- Jim Simons fully exited Microsoft in Q1 2022, selling an estimated $786M.
- Jim Simons's ten largest holdings make up 12% of its $85.2B portfolio in Q1 2022.
- Jim Simons opened 822 new positions and closed 650 in Q1 2022.
- Jim Simons's portfolio value rose 6% quarter-over-quarter to $85.2B.
Based on Renaissance Technologies's 13F filing for Q1 2022, filed 13 May 2022.